“Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low” (2020) Innovative Journal of Medical and Health Sciences, 10(06), pp. 959–960. Available at: http://innovativejournal.in/index.php/ijmhs/article/view/2988 (Accessed: 23 October 2026).